Navigation Links
Genes key to staph disease severity, drug resistance found hitchhiking together
Date:7/31/2009

Scientists studying Staphylococcus bacteria, including methicillin-resistant S. aureus (MRSA), have discovered a potent staph toxin responsible for disease severity. They also found the gene for the toxin traveling with a genetic component of Staphylococcus that controls resistance to antibiotics. The study, now online in PLoS Pathogens, shows for the first time that genetic factors that affect Staphylococcus virulence and drug resistance can be transferred from one strain to another in one exchange event.

One of the ways Staphylococcus bacteria become drug-resistant is through horizontal gene transfer, whereby resistance genes move from one bacterium to another. Staph bacteria also can exchange virulence genes using the same mechanism, but this was previously assumed to occur separately from the transfer of antibiotic resistance.

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, led the study. They collaborated with researchers at the University of Tubingen in Germany and the University of Medicine and Dentistry of New Jersey.

"The discovery that bundled genes determine virulence and antimicrobial resistance suggests a new research focus for scientists trying to better prevent and treat serious staph infections," says Anthony S. Fauci, M.D., NIAID director.

The research involved more than 100 strains of S. aureus and S. epidermidis, both bacteria found on the skin of most people. In recent decades, these bacteria have become increasingly virulent, often causing severe disease that can be resistant to traditional antibiotics such as methicillin.

The studies were directed by NIAID senior investigator Michael Otto, Ph.D. In 2007, he and his colleagues found that staphylococci secrete toxins of the phenol-soluble modulin (PSM) family that are primarily responsible for attracting and killing human white blood cells called neutrophils. This process is critical for the ability of S. aureusincluding community-acquired MRSAto cause disease.

While screening S. aureus and S. epidermidis strains, Dr. Otto's group noticed that some strains produced one additional, previously unknown, PSM toxin. The researchers hypothesized that the toxin was somehow connected to drug resistance. This idea surfaced because the toxin appeared in 10 percent of all MRSA strains and 68 percent of all methicillin-resistant S. epidermidis strains analyzedwhereas the researchers did not find it in strains of S. aureus or S. epidermidis that are sensitive to methicillin.

The research group confirmed its theory by identifying the specific location that encodes the toxin, which was in gene clusters that control drug resistance, known as SCCmec. The group named the new toxin PSM-mec.

"This work represents a previously unknown example of a toxin hitchhiking on staphylococcal mobile genetic elements that are primarily in charge of transferring antibiotic resistance," says Dr. Otto. He adds that the finding "should alert the research community that aggressive, drug-resistant staph can evolve more quickly than we assumed."

The research group is continuing its study of PSM-mec in S. epidermidis, where the toxin is more prevalent. Ultimately, being able to neutralize PSM-mec and other toxins that attack human defenses could lead to new treatments for S. aureus and S. epidermidis disease.


'/>"/>

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
406-375-9690
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Suicide Genes Help Slow Ovarian Tumor Growth in Mice
2. Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth
3. Five Hypertension Genes Found in Black Americans
4. Anti-angiogenesis treatment improves hearing in some NF2 patients
5. Genes Linked to Cholesterol in Cells Are Identified
6. Australian researchers identify genes that cause melanoma
7. News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes
8. Five Genesis HealthCare Centers To Be Awarded Prestigious National Award
9. Hundreds of Genes Could Be Linked to ADHD
10. Cardiogenesis Corporation Names Paul J. McCormick Executive Chairman
11. Genes May Raise Risk of Neuroblastoma in Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... , ... Whole Health Supply, LLC is announcing the release of an updated version of their ... , The 2017 edition has wide jaws that will accommodate nails up to 4mm ... as diabetics. This handle is reinforced for extra strength when pressing down on dense nails ...
(Date:1/15/2017)... (PRWEB) , ... January 15, 2017 , ... The Gravity ... location in Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing ... Gravity Vaults sixth location, including three in New Jersey and two in New York. ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... frame transition from one clip to the next. , To use “Cut-Out First” ...
(Date:1/13/2017)... ... 2017 , ... With the increasing public preference for chemical-free ... organic alternatives for customers who have grown more conscious about maintaining their health ... activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained their company’s ...
(Date:1/13/2017)... , ... January 13, 2017 , ... Friday, January 13 ... of the game room, increasing the size of the location to 90,000 square feet. ... 8-hole mini golf course that takes customers on an educational tour of the historic ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Research and Markets has announced the addition of the ... their offering. ... Cystic fibrosis (CF) is a progressive genetic condition and is the ... regulator (CFTR) gene from both parents. The defective CFTR genes produce ... the buildup of a thick and sticky mucus in the lungs ...
(Date:1/13/2017)... , Jan. 12, 2017  Albertsons Companies proudly ... Commission for Health Care (ACHC) for its specialty ... food and drug chain with this accreditation and ... patients. Accreditation by ACHC reflects Albertsons ... to facilitate a higher level of performance and ...
(Date:1/13/2017)... , Jan. 13, 2017  Biologics Prescribers ... Drug Administration (FDA) for issuing final guidance ... medicines. This policy is an important win ... is essential for pharmacovigilance, patient safety and ... has voiced to FDA, we remain concerned with "random" ...
Breaking Medicine Technology: